HPV Oral Cancer Burden; Cutting Chemo Time; Playing Hardball With Roundup

Human papillomavirus (HPV) accounts for 75% of all new cases of oropharyngeal cancer, primarily affecting white men younger than 65. (Cancer Epidemiology, Biomarkers & Prevention, Brigham and Women's Hospital)

The incidence of HPV-associated tonsil cancer continues to increase across the spectrum of socioeconomic status. (Fox Chase Cancer Center)

A skin patch designed to deliver cancer therapy in 60 seconds passed an early test in mice. (CNBC)

More evidence that survivors of childhood cancer have an increased risk of heart disease. (American Heart Association)

New clues to the cause of permanent hair loss caused by chemotherapy. (Nature Communications)

Internal emails showed that one Monsanto executive wanted to play hardball with a group of mothers who were urging the company to stop making the popular weedkiller Roundup. (Environmental Working Group)

Positive results from a first-ever clinical study of laser-activated gold nanoparticles to treat localized prostate cancer. (Mount Sinai Health System, Rice University, Nanospectra Biosciences)

Trovagene announced positive initial results from a small trial of its PLK1 inhibitor, onvansertib, in combination with abiraterone (Zytiga) in metastatic castration-resistant prostate cancer.

A New Jersey appellate court overturned a restraining order that held up implementation of the state's aid-in-dying law. (Compassion & Choices)

Annual cigarette consumption in England decreased by 1.5 billion from 2011 to 2018. (Cancer Research UK, JAMA Network Open)

A new phone app allows patients with cancer to communicate directly with their doctors in real time from home or elsewhere. (Sheba Medical Center, Telesofia Medical)

Comment